DECXF yields 3703.70% · PFE yields 6.13%● Live data
📍 DECXF pulled ahead of the other in Year 1
Combined, DECXF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DECXF + PFE for your $10,000?
Decade Resources Ltd., an exploration stage company, engages in the acquisition, exploration, and evaluation of mineral properties in Canada. The company holds a 65% interest in the Red Cliff property in north of Stewart, British Columbia; a 100% interest in the Goat property that consists of 8 claims totaling 1210.40 hectares located in British Columbia; and an option to earn a 100% interest in the Terrace property covering 48 contiguous mineral claims situated in British Columbia. It also holds an option agreement to acquire up to 75% interest in the Del Norte property comprising 5,830.16 hectares in 13 separate claims located in east British Columbia; and a 100% interest in the Grassy property that contains approximately 830.20 hectares in 2 separate claims situated in north of Stewart, British Columbia. In addition, the company holds interests in the Premier East property, which includes approximately 600 hectares in 7 separate claims located in British Columbia; and an option agreement to acquire up to 75% interest in the Lord Nelson property comprising of 2630 hectares in 6 separate claims situated in British Columbia. The company was incorporated in 2006 and is headquartered in Stewart, Canada.
Full DECXF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.